Overview
- 8 FDA inspections are on record.
- 2 inspections produced a Form 483.
- The most recent recorded inspection date is 2025-05-06.
At a glance
Inspections
8
Form 483s
2
EIRs
3
Last outcome
Clean
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 30 Apr 2025 – 6 May 2025 | Human Drugs | Clean | |
| 17 Apr 2019 – 22 Apr 2019 | Human Drugs | Clean | |
| 11 Sep 2017 – 15 Sep 2017 | Human Drugs | Clean | |
| 7 Nov 2016 – 9 Nov 2016 | Human Drugs | Clean | |
| 26 Aug 2016 – 29 Aug 2016 | Human Drugs | Clean | |
| 8 Apr 2013 – 12 Apr 2013 | Human Drugs | 483 | View 483 → |
| 12 Nov 2010 | Not recorded | Clean | |
| 28 Aug 2009 | Not recorded | 483 | On file |
Observations on record
Form 483 observations cited at this site, most recent first.
12 Apr 2013
21 CFR 211.22(d)
Procedures not in writing, fully followed
Cited by Latorie S Jones, Torrance J Slayton
12 Apr 2013
21 CFR 211.160(b)
Scientifically sound laboratory controls
Cited by Latorie S Jones, Torrance J Slayton
12 Apr 2013
21 CFR 211.180(b)
Record maintenance 1 year (except exempt OTC)
Cited by Latorie S Jones, Torrance J Slayton
Investigators
FDA investigators tied to this site in the record.
Camerson E Moore2 insp.
Jason R Caballero2 insp.
Shanna N Purdy1 insp.
Patty P Kaewussdangkul1 insp.
Latorie S Jones1 insp.
Torrance J Slayton1 insp.
Blondell W Johnson1 insp.
Johann M Fitch1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.160(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.180(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.22(d) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind DPT Laboratories Ltd.'s 2 Form 483s
Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat